Efficacy of liraglutide combined with insulin pump in type 2 diabetes

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900024828

Enrollment

Unknown

Registered

2019-07-29

Start date

2019-07-31

Completion date

Unknown

Last updated

2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes

Interventions

treatment group:Insulin pump combined with liraglutide

control group:Insulin pump

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) To meet the diagnostic criteria for type 2 diabetes mellitus with poor blood sugar control; (2) aged 18 to 70, men and women are not limited; (3) HbA1c is greater than or equal to 9%; (4) patients and their families agree and sign agreements.

Exclusion criteria

Exclusion criteria: (1) diabetes mellitus with pregnancy; (2) patients with cerebral infarction or severe mental illness, unconsciousness; (3) patients with infectious diseases such as active pulmonary tuberculosis; (4) patients with severe cardiopulmonary and liver and kidney dysfunction; (5) insulin allergists; (6) those who do not cooperate with drugs.

Design outcomes

Primary

Measure	Time frame
Fasting blood glucose;Postprandial blood glucose;Insulin;C peptide;glycosylated hemoglobin;	—

Countries

China

Contacts

Public ContactZhu Yan

XuZhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine

zhuyan986@sina.com+86 13914870150

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026